Cancer BiologybioRxivPreprint
Oncogenic Role of Aberrant EZH2 in Hepatoblastoma
Kathryn Glaser, Lara E. Berklite, Brian T Hickner…·Alexander J. Bondoc
This study identifies EZH2 as an oncogenic driver in hepatoblastoma, showing its role in promoting tumor progression through epigenetic silencing and noncanonical signaling, and highlights its potential as a therapeutic target.